Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
45.75
-40.75
-89.07%
Share Warrants & Outstandings
Total Reserve
765.35
4,171.66
-3,406.31
-81.65%
Shareholder's Funds
770.35
4,217.41
-3,447.06
-81.73%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-41.56
-69.30
27.74
40.03%
Other Long Term Liabilities
38.45
67.62
-29.17
-43.14%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
56.57
-50.25
-88.83%
Total Non-Current Liabilities
3.21
54.89
-51.68
-94.15%
Current Liabilities
Trade Payables
456.30
151.60
304.70
200.99%
Other Current Liabilities
140.17
364.07
-223.90
-61.50%
Short Term Borrowings
0.00
2.50
-2.50
-100.00%
Short Term Provisions
106.53
51.34
55.19
107.50%
Total Current Liabilities
703.00
569.51
133.49
23.44%
Total Liabilities
1,476.56
4,841.81
-3,365.25
-69.50%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
1,418.48
-1,256.07
-88.55%
Less: Accumulated Depreciation
133.87
694.86
-560.99
-80.73%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
723.62
-695.08
-96.06%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
7.64
-7.64
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
69.97
541.35
-471.38
-87.07%
Other Non Current Assets
0.00
56.35
-56.35
-100.00%
Total Non-Current Assets
134.21
1,328.96
-1,194.75
-89.90%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
548.50
475.92
72.58
15.25%
Sundry Debtors
184.88
193.09
-8.21
-4.25%
Cash and Bank
536.70
2,800.98
-2,264.28
-80.84%
Other Current Assets
16.20
32.09
-15.89
-49.52%
Short Term Loans and Advances
56.07
13.46
42.61
316.57%
Total Current Assets
1,342.35
3,512.85
-2,170.50
-61.79%
Net Current Assets (Including Current Investments)
639.35
2,943.34
-2,303.99
-78.28%
Total Current Assets Excluding Current Investments
1,342.35
3,512.85
-2,170.50
-61.79%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
4,841.81
-3,365.25
-69.50%
Contingent Liabilities
98.41
211.92
-113.51
-53.56%
Total Debt
0.00
2.50
-2.50
-100.00%
Book Value per share (adjusted)
308.14
921.84
-613.70
-66.57%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024






